Payment Breakdown by Category
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | $824,298 | 235 | 64.1% |
| Consulting Fee | $246,605 | 63 | 19.2% |
| Travel and Lodging | $174,468 | 304 | 13.6% |
| Food and Beverage | $22,091 | 259 | 1.7% |
| Honoraria | $18,800 | 5 | 1.5% |
| Education | $23.84 | 2 | 0.0% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| AstraZeneca Pharmaceuticals LP | $640,133 | 463 | $0 (2024) |
| Novo Nordisk Inc | $277,529 | 200 | $0 (2024) |
| Corcept Therapeutics | $120,472 | 50 | $0 (2024) |
| Hikma Pharmaceuticals USA | $66,846 | 19 | $0 (2024) |
| Janssen Pharmaceuticals, Inc | $48,109 | 40 | $0 (2020) |
| Alnylam Pharmaceuticals Inc. | $17,980 | 2 | $0 (2024) |
| Janssen Scientific Affairs, LLC | $13,042 | 14 | $0 (2018) |
| PFIZER INC. | $12,800 | 4 | $0 (2024) |
| Novo Nordisk AS | $9,865 | 3 | $0 (2023) |
| Boehringer Ingelheim (Phil.) Inc. | $9,060 | 2 | $0 (2021) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $142,981 | 71 | Corcept Therapeutics ($65,974) |
| 2023 | $100,208 | 50 | Corcept Therapeutics ($51,048) |
| 2022 | $76,211 | 54 | AstraZeneca Pharmaceuticals LP ($47,930) |
| 2021 | $81,276 | 47 | AstraZeneca Pharmaceuticals LP ($26,752) |
| 2020 | $179,452 | 85 | AstraZeneca Pharmaceuticals LP ($112,212) |
| 2019 | $186,919 | 140 | AstraZeneca Pharmaceuticals LP ($112,547) |
| 2018 | $290,960 | 225 | AstraZeneca Pharmaceuticals LP ($165,930) |
| 2017 | $228,279 | 196 | AstraZeneca Pharmaceuticals LP ($145,682) |
All Payment Transactions
868 individual payment records from CMS Open Payments — Page 1 of 35
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/31/2024 | Regeneron Pharmaceuticals, Inc. | — | Travel and Lodging | In-kind items and services | $303.97 | General |
| 12/31/2024 | Regeneron Pharmaceuticals, Inc. | — | Food and Beverage | In-kind items and services | $149.28 | General |
| 12/31/2024 | Regeneron Pharmaceuticals, Inc. | — | Food and Beverage | In-kind items and services | $132.84 | General |
| 12/31/2024 | Regeneron Pharmaceuticals, Inc. | — | Food and Beverage | In-kind items and services | $105.64 | General |
| 12/31/2024 | Regeneron Pharmaceuticals, Inc. | — | Food and Beverage | In-kind items and services | $102.51 | General |
| 12/31/2024 | Regeneron Pharmaceuticals, Inc. | — | Food and Beverage | In-kind items and services | $75.63 | General |
| 12/31/2024 | Regeneron Pharmaceuticals, Inc. | — | Food and Beverage | In-kind items and services | $65.99 | General |
| 12/31/2024 | Regeneron Pharmaceuticals, Inc. | — | Food and Beverage | In-kind items and services | $61.30 | General |
| 12/31/2024 | Regeneron Pharmaceuticals, Inc. | — | Food and Beverage | In-kind items and services | $42.16 | General |
| 12/31/2024 | Regeneron Pharmaceuticals, Inc. | — | Food and Beverage | In-kind items and services | $33.12 | General |
| 12/31/2024 | Regeneron Pharmaceuticals, Inc. | — | Food and Beverage | In-kind items and services | $24.62 | General |
| 12/17/2024 | Regeneron Pharmaceuticals, Inc. | — | Food and Beverage | In-kind items and services | $150.00 | General |
| 12/16/2024 | Regeneron Pharmaceuticals, Inc. | — | Food and Beverage | In-kind items and services | $135.51 | General |
| 12/16/2024 | Regeneron Pharmaceuticals, Inc. | — | Food and Beverage | In-kind items and services | $108.13 | General |
| 12/16/2024 | Regeneron Pharmaceuticals, Inc. | — | Food and Beverage | In-kind items and services | $53.38 | General |
| 12/16/2024 | Regeneron Pharmaceuticals, Inc. | — | Food and Beverage | In-kind items and services | $34.22 | General |
| 12/16/2024 | Regeneron Pharmaceuticals, Inc. | — | Food and Beverage | In-kind items and services | $20.53 | General |
| 11/13/2024 | Xeris Pharmaceuticals, Inc. | RECORLEV (Drug) | Food and Beverage | In-kind items and services | $133.07 | General |
| Category: Adrenal steroidogenesis inhibitor | ||||||
| 11/06/2024 | Corcept Therapeutics | Korlym (Drug) | Travel and Lodging | Cash or cash equivalent | $598.75 | General |
| Category: Endocrinology | ||||||
| 11/06/2024 | Corcept Therapeutics | Korlym (Drug) | Travel and Lodging | Cash or cash equivalent | $526.95 | General |
| Category: Endocrinology | ||||||
| 11/06/2024 | Corcept Therapeutics | Korlym (Drug) | Travel and Lodging | Cash or cash equivalent | $33.00 | General |
| Category: Endocrinology | ||||||
| 11/06/2024 | Corcept Therapeutics | Korlym (Drug) | Travel and Lodging | Cash or cash equivalent | $32.00 | General |
| Category: Endocrinology | ||||||
| 11/03/2024 | Eli Lilly and Company | MOUNJARO (Drug) | Food and Beverage | In-kind items and services | $76.45 | General |
| Category: Diabetes | ||||||
| 10/30/2024 | Corcept Therapeutics | Korlym (Drug) | Travel and Lodging | Cash or cash equivalent | $676.93 | General |
| Category: Endocrinology | ||||||
| 10/17/2024 | Corcept Therapeutics | Korlym (Drug) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $8,000.00 | General |
| Category: Endocrinology | ||||||
About Dr. Ralph Defronzo, MD
Dr. Ralph Defronzo, MD is a Endocrinology, Diabetes & Metabolism healthcare provider based in San Antonio, Texas. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 08/24/2006. The National Provider Identifier (NPI) number assigned to this provider is 1851408843.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Ralph Defronzo, MD has received a total of $1.3M in payments from pharmaceutical and medical device companies, with $142,981 received in 2024. These payments were reported across 868 transactions from 32 companies. The most common payment nature is "Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program" ($824,298).
Practice Information
- Specialty Endocrinology, Diabetes & Metabolism
- Other Specialties Diabetes & Metabolism
- Location San Antonio, TX
- Active Since 08/24/2006
- Last Updated 05/02/2011
- Taxonomy Code 207RE0101X
- Entity Type Individual
- NPI Number 1851408843
Products in Payments
- FARXIGA (Drug) $590,419
- Korlym (Drug) $120,472
- Victoza (Drug) $104,318
- Ozempic (Drug) $101,744
- INVOKANA (Drug) $61,133
- BYDUREON (Drug) $36,651
- JARDIANCE (Drug) $16,360
- GLYXAMBI (Drug) $9,060
- KIDNEYINTELX BLOOD COLLECTION CONVENIENCE KIT (Device) $8,688
- Kerendia (Drug) $8,036
- Tresiba (Drug) $7,474
- JANUVIA (Drug) $4,045
- CYCLOSET (Drug) $2,490
- LOKELMA (Drug) $1,270
- Xultophy (Drug) $260.00
- RECORLEV (Drug) $133.07
- AFREZZA (Drug) $126.60
- CoreValve Evolut (Device) $125.00
- Strensiq (Drug) $125.00
- JANUMET (Drug) $123.99
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Endocrinology, Diabetes & Metabolism Doctors in San Antonio
Eugenio Cersosimo, Md, MD
Endocrinology, Diabetes & Metabolism — Payments: $1.3M
Firas Akhrass, Md, MD
Endocrinology, Diabetes & Metabolism — Payments: $868,751
Dr. Jeannie Baquero, M.d, M.D
Endocrinology, Diabetes & Metabolism — Payments: $668,321
Kathleen Hands, M.d, M.D
Endocrinology, Diabetes & Metabolism — Payments: $609,314
Carolina Solis-Herrera, Md, MD
Endocrinology, Diabetes & Metabolism — Payments: $481,511
William Trigoso, Md, MD
Endocrinology, Diabetes & Metabolism — Payments: $231,800